Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative tamsulosin once daily vs twice daily vs tadalafil before retrograde intrarenal surgery
PACTR202605538229860Phase 4Recruiting
- Sponsor
- Faculty of Medicine, Tanta University
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tamsulosin and tadalafil in nephrolithiasis (3 arms), sponsored by Faculty of Medicine, Tanta University. Primary endpoint: Efficacy in facilitating ureteroscope access during RIRS. Started Mar 2026; status: recruiting.
02
Drugs
tamsulosintadalafil
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on PACTR202605538229860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202605538229860.